← Leaderboards
Thomas E Lane
University Of California Irvine
$15,456,557
Attributed
$19,435,766
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,635,927 · 9
FDA$1,799,839 · 1
By mechanism
R01$13,359,413 · 5
R35$4,164,357 · 1
P01$876,333 · 1
T32$707,318 · 1
R29$325,345 · 1
R13$3,000 · 1
Top collaborators
- Robert S Fujinami6 shared
- Jeanne Frances Loring6 shared
- Kim Green4 shared
- Virginia Eunice Kimonis3 shared
- Albert R La Spada3 shared
- Xiangmin Xu3 shared
Others in their field
Top investigators on “Murine Hepatitis Virus”
- Susan R. Weiss · University Of Pennsylvania$16,294,519
- Charles M. Rice · Rockefeller University$11,530,390
- Ralph S Baric · University Of North Carolina Chapel Hill$9,804,346
- Mark R Denison · Vanderbilt University$8,765,651
- Ellen A Robey · University Of California Berkeley$8,011,265
- Cornelia C Bergmann · Cleveland Clinic Lerner Com-Cwru$7,229,339
Research focus
Murine Hepatitis VirusMultiple SclerosisMacrophageDemyelinating DiseasesDemyelinationsInfectionVirus DiseasesCellsNeuraxisInflammationViralChemokineMediatingRepairedHistologicInflammatoryMyelinOligodendrogliaT-LymphocyteNeurotropicPathogenesisMolecularEngraftmentRemyelination
Grant awards (59)
Defining mechanisms of disease and repair in a viral model of multiple sclerosis$871,109
R35 · FY2025 · NS · contact PI
Neuroimmunology Training Program at the University of California, Irvine$200,556
T32 · FY2025 · NS · contact PI
Defining mechanisms of disease and repair in a viral model of multiple sclerosis$846,461
R35 · FY2024 · NS · contact PI
Neuroimmunology Training Program at the University of California, Irvine$188,956
T32 · FY2024 · NS · contact PI
Defining mechanisms of disease and repair in a viral model of multiple sclerosis$874,084
R35 · FY2023 · NS · contact PI
Engineered AAV vectors for combinatorial treatment of rare genetic brain diseases$599,924
R01 · FY2023 · FD
Neuroimmunology Training Program at the University of California, Irvine$199,590
T32 · FY2023 · NS · contact PI
Defining mechanisms of disease and repair in a viral model of multiple sclerosis$875,447
R35 · FY2022 · NS · contact PI
Engineered AAV vectors for combinatorial treatment of rare genetic brain diseases$599,938
R01 · FY2022 · FD
Neuroimmunology Training Program at the University of California, Irvine$118,216
T32 · FY2022 · NS · contact PI
Engineered AAV vectors for combinatorial treatment of rare genetic brain diseases$599,977
R01 · FY2021 · FD
Defining mechanisms of disease and repair in a viral model of multiple sclerosis$697,256
R35 · FY2020 · NS · contact PI
Viral-induced axonopathy: mechanisms of damage and repair$273,982
R01 · FY2020 · NS · contact PI
FASEB's "The Translational Neuroimmunology Conference: From Mechanisms to Therapeutics."$3,000
R13 · FY2020 · NS · contact PI
Chemokines and Viral-Induced Neurologic Disease$325,938
R01 · FY2019 · NS · contact PI
Human neural precursor cell-mediated therapy in a viral model of demyelination$307,857
R01 · FY2019 · NS · contact PI
Human neural precursor cell-mediated therapy in a viral model of demyelination$250,145
R01 · FY2019 · NS · contact PI
Viral-induced axonopathy: mechanisms of damage and repair$207,045
R01 · FY2019 · NS · contact PI
Viral-induced axonopathy: mechanisms of damage and repair$161,730
R01 · FY2019 · NS · contact PI
Human neural precursor cell-mediated therapy in a viral model of demyelination$558,002
R01 · FY2018 · NS · contact PI
Viral-induced axonopathy: mechanisms of damage and repair$368,775
R01 · FY2018 · NS · contact PI
Chemokines and Viral-Induced Neurologic Disease$325,938
R01 · FY2018 · NS · contact PI
Human neural precursor cell-mediated therapy in a viral model of demyelination$558,002
R01 · FY2017 · NS · contact PI
Viral-induced axonopathy: mechanisms of damage and repair$368,775
R01 · FY2017 · NS · contact PI
Chemokines and Viral-Induced Neurologic Disease$325,938
R01 · FY2017 · NS · contact PI
Human neural precursor cell-mediated therapy in a viral model of demyelination$558,002
R01 · FY2016 · NS · contact PI
Viral-induced axonopathy: mechanisms of damage and repair$368,775
R01 · FY2016 · NS · contact PI
Chemokines and Viral-Induced Neurologic Disease$325,938
R01 · FY2016 · NS · contact PI
Human neural precursor cell-mediated therapy in a viral model of demyelination$570,252
R01 · FY2015 · NS · contact PI
Viral-induced demyelination and neural stem cell-mediated remyelination$309,838
R01 · FY2015 · NS · contact PI
Chemokines and Viral-Induced Neurologic Disease$242,457
R01 · FY2015 · NS · contact PI
Viral-induced demyelination and neural stem cell-mediated remyelination$306,740
R01 · FY2014 · NS · contact PI
Chemokines and Viral-Induced Neurologic Disease$285,342
R01 · FY2014 · NS · contact PI
Chemokines and Viral-Induced Neurologic Disease$308,041
R01 · FY2013 · NS · contact PI
Viral-induced demyelination and neural stem cell-mediated remyelination$232,068
R01 · FY2013 · NS · contact PI
Viral-induced demyelination and neural stem cell-mediated remyelination$74,103
R01 · FY2013 · NS · contact PI
Chemokines and Viral-Induced Neurologic Disease$321,113
R01 · FY2012 · NS · contact PI
Viral-induced demyelination and neural stem cell-mediated remyelination$316,531
R01 · FY2012 · NS · contact PI
Viral-induced demyelination and neural stem cell-mediated remyelination$329,088
R01 · FY2011 · NS · contact PI
Chemokines and Viral-Induced Neurologic Disease$322,781
R01 · FY2011 · NS · contact PI
Chemokines and Viral-Induced Neurologic Disease$291,628
R01 · FY2010 · NS · contact PI
Chemokines and Viral-Induced Neurologic Disease$295,923
R01 · FY2009 · NS · contact PI
Chemokines and Viral-Induced Neurologic Disease$297,138
R01 · FY2008 · NS · contact PI
Chemokines and Viral-Induced Neurologic Disease$298,233
R01 · FY2007 · NS · contact PI
Chemokine IP-10 and Viral-Induced Demyelination$152,281
P01 · FY2007 · NS · contact PI
Chemokines and Viral-Induced Neurologic Disease$308,156
R01 · FY2006 · NS · contact PI
Chemokine IP-10 and Viral-Induced Demyelination$180,308
P01 · FY2006 · NS · contact PI
Chemokines and Viral-Induced Neurologic Disease$301,139
R01 · FY2005 · NS
Chemokine IP-10 and Viral-Induced Demyelination$180,522
P01 · FY2005 · NS
Chemokines and Viral-Induced Neurologic Disease$243,949
R01 · FY2004 · NS
Chemokine IP-10 and Viral-Induced Demyelination$180,562
P01 · FY2004 · NS
Chemokines and Viral-Induced Neurologic Disease$55,647
R01 · FY2004 · NS
Chemokines and Viral-Induced Neurologic Disease$244,452
R01 · FY2003 · NS
Chemokine IP-10 and Viral-Induced Demyelination$182,660
P01 · FY2003 · NS
Chemokines and Viral-Induced Neurologic Disease$75,200
R01 · FY2003 · NS
Chemokines and Viral-Induced Neurologic Disease$244,913
R01 · FY2002 · NS
PATHOLOGICAL MECHANISMS OF DEMYELINATION$111,631
R29 · FY2002 · NS
PATHOLOGICAL MECHANISMS OF DEMYELINATION$108,407
R29 · FY2001 · NS
PATHOLOGICAL MECHANISMS OF DEMYELINATION$105,307
R29 · FY2000 · NS